News
Feed
Events
Feed
News
+ Events
Feed

Moderna, Inc. (accesswire)

  • ISIN US60770K1079
  • Country United States of America

Latest News

8 September 2022

13:00 Corporate

Moderna, Inc. (accesswire)

Corporate

Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day

1 September 2022

15:35 Corporate

Moderna, Inc. (accesswire)

Corporate

EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna’s Omicron-Targeting Bivalent Booster in the European Union

29 August 2022

12:30 Corporate

Moderna, Inc. (accesswire)

Corporate

Moderna, Inc.: Swissmedic Authorizes Moderna’s Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214

15 August 2022

13:30 Corporate

Moderna, Inc. (accesswire)

Corporate

Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna’s Omicron-Containing Bivalent Booster in the UK

9 August 2022

12:40 Corporate

Moderna, Inc. (accesswire)

Corporate

Moderna And the European Commission (EC) Amend Covid-19 Vaccine Agreement to Supply Omicron-Containing Bivalent Candidates; EC Purchases Additional 15 million Doses

22 July 2022

14:05 Corporate

Moderna, Inc. (accesswire)

Corporate

EMA Committee for Medicinal Products for Human Use (CHMP) Recommends Use of the Moderna COVID-19 Booster in Adolescents (12-17 Years) in the European Union

2 June 2022

13:00 Corporate

Moderna, Inc. (accesswire)

Corporate

Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement

29 April 2022

17:30 Corporate

Moderna, Inc. (accesswire)

Corporate

Moderna Files to Expand Conditional Marketing Authorization for Its COVID-19 Vaccine to Include Children Six Months to Under Six Years in The European Union

Upcoming Events

No Events found